← Open Payments lookup

MARK CANNING: Open Payments

NPI 1366548141 · VAUXHALL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$289 in 16 payments from 8 companies in 2025. Trend: 2023 $88 · 2024 $129 · 2025 $289

Food & beverage: $289
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc4$74
Alkermes, Inc.3$56
Teva Pharmaceuticals USA, Inc.3$49
Otsuka America Pharmaceutical, Inc.2$40
Neurocrine BioSciences, Inc.1$19
ABBVIE INC.1$18
Vanda Pharmaceuticals Inc.1$17
E.R. Squibb & Sons, L.L.C.1$16

Products named: INVEGA SUSTENNA, ARISTADA, UZEDY, ABILIFY ASIMTUFII, REXULTI, INGREZZA, VRAYLAR, HETLIOZ.

Industry payments across NJ — which companies pay providers there.